Board of Directors

Gianna Arnold is a Principal with Miles & Stockbridge, P.C. Gianna is an experienced entrepreneur and corporate executive, and has first hand knowledge and practice in matters such as formation, financing, strategic alliances, mergers/acquisitions, business development; knowledge management including developing and managing intellectual property portfolios, preparation of business plans/executive summaries, and preparation of grant proposals.  She holds a masters degree (Biotechnology) from Johns Hopkins; a masters degree (Intellectual Property) from Franklin Pierce Law Center; a juris doctorate from Franklin Pierce Law Center; and a Business Management Certificate, from University of Utah.  Gianna is a frequent symposium organizer, presenter, and author and has been an active member in WIB for many years, serving on the Program Committee planning events for the Entrepreneur & Executive Forum and Baltimore.

Phyllis Dillinger is the Executive Vice President and C.F.O. of KPL. KPL manufactures and distributes antibodies and reagents to the Life Science Research community. During her 13 years with KPL, Ms. Dillinger completed a divestiture, spun off a separate Genomics business and most recently relocated the organization to a 30,000 square foot state of the art facility. Prior to joining KPL, she was C.F.O. of Sopha Medical the French held U.S. subsidiary manufacturing gamma cameras for 10 years. During her stay at Sopha, sales grew from $1M to $42M. She completed a $85M dollar merger between Sopha Medical and Summit Vision and relocated the new organization to Cleveland, Ohio. Ms. Dillinger holds an M.B.A. from The George Washington University.

Susan E. Hendrickson is a founding member of Women in Bio and a partner in the intellectual property and technology practice group of Arnold & Porter LLP. She specializes in licensing and technology transactions and has 15 years of experience in the life sciences industry. Ms. Hendrickson regularly represents public and private pharmaceutical, biotech, medical device, and other healthcare related companies in connection with their licensing matters and commercial arrangements. She has advised on life sciences transactions involving all phases of the product life cycle, from early research, development, and financing efforts, through clinical trials, product approval, manufacturing, marketing and promotion, new market expansions, and next generation product development. Among other matters, she has represented pharmaceutical and other life sciences companies in connection with licensing transactions, research and development agreements, clinical trial agreements, co-promotion agreements, feasibility and proof of concept studies, distribution agreements, manufacturing and supply arrangements, strategic alliances, mergers and acquisitions, product divestitures, and in connection with the arbitration and settlement of commercial disputes and Hatch-Waxman litigation. She also has substantial experience in connection with online and electronic healthcare related businesses. She has received recognition in Chambers and other publications for her expertise in intellectual property and technology transactions.

Cynthia Hu is Chief Operating Officer & General Counsel of EntreMed, Inc. Prior to joining EntreMed, Ms. Hu served as a senior attorney for the corporate and finance group at Powell Goldstein LLP, in Washington, DC., where she advised clients on all corporate matters, including complex public and private financings, mergers and acquisitions, SEC and regulatory compliance, and corporate governance and compliance. Before that, Ms. Hu served as counsel for ING Annuities (formerly Golden American Life Insurance Company) and an attorney with the law firms of Klehr, Harrison, Harvey & Branzburg, LLP and Littman & Krooks, LLP focusing on corporate transactions and compliance with corporate and securities laws.

Lynn Johnson Langer, Ph.D., M.B.A. is Director of Enterprise and Regulatory Affairs Programs in the Center for Biotechnology Education at Johns Hopkins University. She is on the board of directors at TEDCO, the Maryland Technology Development Corporation. She has headed the sales and marketing department of several biotechnology companies and worked as a consultant in the bioscience industry. She founded BioPlan Associates, a management and marketing consulting firm. She has worked extensively with leading biomedical and high technology companies. Dr. Langer has been involved in "think tanks" with organizations such as NASA, developing potential biotechnology products to be tested in space and others in the biomedical field. She has published over fifty articles and two book chapters mainly in business areas of biotechnology and has taught a variety of graduate courses in biotechnology and business. She attended Tulane University and the University of Maryland for her undergraduate degree in microbiology. She later received her MBA from Johns Hopkins University, and received the Stegman Award for academic excellence in Administrative Science. She received her Ph.D. in Leadership and Change from Antioch University. While a student at Johns Hopkins she co-founded the Hopkins Professional Women's Network. Dr. Langer currently teaches Managing and Leading Biotechnology Professionals, Bioscience Communication, Emerging Issues in Biotechnology and Proseminar in Biotechnology. She also does executive coaching and management consulting with bioscience organizations.

Carol Nacy, Ph.D. was Executive Vice President and CSO at EntreMed, Inc. from 1993 through its successful public offering in June 1996. She left EntreMed in November 1996 to establish Sequella, Inc. and was part-time CSO (1997-98) for Anergen, Inc., a California company focused on autoimmune diseases. There, she reorganized the scientific staff and approach and positioned the company for acquisition by Corixa Corp. in December 1998. Dr. Nacy became a full-time CEO and Chair of Sequella and began drawing salary in January 1999. She is a member of the Board of Directors of several companies(ASMResources, TolerGenics, Social and Scientific Systems) and non-profit agencies (Sequella Foundation, Women in BIO). Before her business experience, she was a Career Scientist and Science Manager at the Walter Reed Army Institute of Research and the National Institutes of Health for seventeen years.

Lyn Rossano is a Senior Vice President of Life Sciences at Navigators Management Company. Her focus is on developing and structuring comprehensive insurance plans for life sciences companies. She specializes in managing risk for biotechnology, medical device, and pharmaceutical companies, with a coverage concentration in Product Liability and Errors and Omissions. Ms. Rossano began her insurance career in 1984 as an underwriter for the American International Group (Lexington Insurance Company) in Boston specializing in healthcare liability and life sciences liability. Prior to taking a four year hiatus to pursue her doctorate in Epidemiology, she pioneered the field of life sciences research risk management and liability insurance during her seven year tenure at the CNA Insurance Company in New York City. Upon returning to the insurance industry, Lyn spent five years with Willis serving as the Life Sciences Practice Leader for North America for the later three years. She then moved to William Gallagher Associates, a leading life sciences boutique brokerage firm, where she produced life sciences business throughout North America. Ms. Rossano is the author of several published scholarly papers based on her research and has presented her work at various academic conferences. She is also a frequent presenter on the topic of life sciences industry liability and risk management topics at industry based seminars and conferences. Ms. Rossano holds a Masters Degree in Epidemiology from Columbia University in New York City. She is currently completing her doctoral degree, also from Columbia University in Epidemiology.